Menu
Back to Journals » OncoTargets and Therapy » Volume 8
Original Research
Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,641 | Dovepress* | 10,379+ | 1,378 | 11,757 | |
| PubMed Central* | 1,262 | 467 | 1,729 | ||
| Totals | 11,641 | 1,845 | 13,486 | ||
|
*Since 3 September 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 1 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar